CIK 0001811115 · <br>Emerging growth company
Renalytix plc
Sign in to watch- Ticker
- RENXF
- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- FY end
- Jun 30
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 29 2071 0570
- Business address
- FINSGATE, 5-7 CRANWOOD STREET, LONDON, United Kingdom
- Former names
- Renalytix AI plc
Securities
- RENXF Common stock OTC
- RNLXY American depositary shares OTC
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 10-K/A Report 10-K/A
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
- RW WD Other RW WD
- CORRESP Other Correspondence Between Filers and SEC Staff
- RW Other RW
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Results of operations
- S-3 Offering Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
Page 6 of 12 · 233 filings